Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection [clinicaltrials:NCT00499720]
Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection [clinicaltrials:NCT00499720]
Bio2RDF identifier
NCT00499720
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00499720
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The primary objective o ...... risk for disease progression.
brief title [clinicaltrials_vocabulary:brief-title]
Aztreonam Lysine for Inhalatio ...... as Aeruginosa Airway Infection
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2007-07-09T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
Aztreonam Lysine for Inhalation
Cystic Fibrosis
Pseudomonas aeruginosa
airway infection
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2011-07-29T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00499720
official title [clinicaltrials_vocabulary:official-title]
Expanded Access Program for Az ...... t Risk for Disease Progression
org study id [clinicaltrials_vocabulary:org-study-id]
EA-US-205-0111
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2011-07-01T00:00:00Z
identifier
clinicaltrials:NCT00499720
title
Aztreonam Lysine for Inhalatio ...... as Aeruginosa Airway Infection
@en
type
label
Aztreonam Lysine for Inhalatio ...... n [clinicaltrials:NCT00499720]
@en